Form 4: Alpha Tau Medical CFO Sells Shares

Alpha Tau Medical Ltd. reports that Chief Financial Officer Raphi Levy sold a total of 32,500 ordinary shares on June 3, 2026, in two separate transactions.

Summary

• Raphi Levy, Chief Financial Officer of Alpha Tau Medical Ltd., reported the sale of ordinary shares on June 3, 2026.
• The sales consisted of 17,500 shares at a price of $10.9005 per share, and 15,000 shares at a price of $10.7571 per share.
• Following these transactions, Mr. Levy beneficially owns 147,680 ordinary shares.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as slightly negative due to the significant share sale by the CFO, which could be interpreted as a bearish signal by the market, despite the lack of explicit negative commentary.

Negatives

• The Chief Financial Officer sold a significant number of shares (32,500) in the company.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings, which report changes in beneficial ownership by insiders, are closely watched by investors. Significant sales by C-suite executives can sometimes signal a lack of confidence in future stock performance, although they can also be for personal financial planning reasons.

Stakeholder Impact

• Shareholders may view the CFO's sale of shares negatively, potentially impacting investor sentiment and share price.

Key Dates

Recommendation

While the sale of shares by the CFO is a point of concern, this filing is purely transactional and does not provide operational or financial performance data. Therefore, a 'hold' recommendation is appropriate, pending further information on the company's performance and the rationale behind the insider's sale.

Keywords

Alpha Tau Medical, Form 4, Insider Trading, Share Sale, Raphi Levy, CFO, Ordinary Shares, SEC Filing